AI Product
Recursion OS
Recursion Pharmaceuticals Platform
- Status
- Active
- Category
- Biotechnology
- Developer
- Recursion Pharmaceuticals
- Industry
- AI in Healthcare
- Country
- United States
Product Ecosystem Map
How this product connects across company, capabilities, technology, and markets on Brel.
Overview
What this product is, what it does, and who develops it.
Providing automated intelligence and execution reliability, Recursion OS is developed by Recursion Pharmaceuticals. The software resolves interoperability bottlenecks across hospital laboratory information systems by systematizing evaluating multi-modal patient care metrics with statistical rigor for technical teams, data leaders, and operational specialists in Healthcare.
Salt Lake City TechBio company industrializing AI-driven drug discovery with clinical-stage assets including REC-4881
What it does
Recursion OS platform combining automated experimentation, proprietary biological and chemical datasets, and AI models to discover and advance clinical-stage drug candidates across oncology, rare disease, and other therapeutic areas.
Who develops it
Internal pipeline development, pharmaceutical partners seeking AI-enabled discovery collaborations, and investors evaluating clinical validation of AI drug discovery platforms.
Capabilities & Features
Verified capabilities and product features from the Brel product record.
Capabilities
- Recursion OS platform combining automated experimentation, proprietary biological and chemical datasets, and AI models to
- automated experimentation
- proprietary biological
- chemical datasets
- and AI models to discover
- advance clinical-stage drug candidates across oncology
- rare disease
- and other therapeutic areas
Technology & Architecture
Technologies, models, and technical structure linked to this product.
Use Cases
Where this product is applied in real operational contexts.
- Recursion OS platform combining automated experimentation, proprietary biological and chemical datasets, and AI models to discover and advance clinical-stage drug candidates across oncology, rare disease, and other therapeutic areas.
Who It Is For
Target users, industries, and deployment context.
Internal pipeline development, pharmaceutical partners seeking AI-enabled discovery collaborations, and investors evaluating clinical validation of AI drug discovery platforms.
Industries
Industries served
- AI in Healthcare
- Biotechnology
Engineered for technical teams, data leaders, and operational specialists in Healthcare, Recursion OS provides an intuitive operational interface backed by robust programmatic access. Deployment architectures accommodate decentralized clinical compute nodes with localized data residency, adhering to enterprise data isolation standards.
Integrations & Deployment
Integration surface and how the product is deployed.
The platform supports modular integration through comprehensive developer documentation and structured REST endpoints. Organizations can embed Recursion OS's intelligence directly into their existing internal dashboards.
Developer
API, documentation, GitHub, and technical resources when verified.
Developer / Company
The organization that builds and ships this product.
Frequently Asked Questions
Answers restated from verified fields on this product profile.
What is Recursion OS?
Recursion OS is an AI solution developed by Recursion Pharmaceuticals, designed to deliver improving early-stage pathology identification fidelity by systematizing accelerating diagnostic evidence extraction and molecular modeling.
What company operates Recursion OS?
Recursion OS is built and maintained by Recursion Pharmaceuticals, based in Salt Lake City, United States.
What functional features does Recursion OS provide?
Documented capabilities include: Recursion OS platform combining automated experimentation, proprietary biological and chemical datasets, and AI models to automated experimentation proprietary biological chemical datasets and AI models to discover advance clinical; stage drug candidates across oncology rare disease and other therapeutic areas; Recursion's AI capability centers on learning from proprietary, relatable biological datasets produced through automated experimentation rather than relying solely on public omics repositories.
What algorithmic models drive Recursion OS?
Recursion OS utilizes Machine Learning, Deep Learning, Predictive Analytics, Vector Database, Clinical Documentation, Healthcare Analytics, supporting deployment across hardened healthcare cloud VPCs adhering to SOC 2 Type II controls.
What teams and user groups utilize Recursion OS?
The software is engineered for Internal pipeline development, pharmaceutical partners seeking AI-enabled discovery collaborations, and investors evaluating clinical validation of AI drug discovery platforms. seeking to mitigate diagnostic imaging backlog and multi-institutional data isolation.
Sources & Verification
Primary sources
Request a correction if you represent this company or believe information is inaccurate.
Related Knowledge
Evergreen architectural research, conceptual foundations, and technical reference guides from the Brel Knowledge Library.